ICON Survey Highlights Scale of Focus on Precision Therapies in Increasingly Complex Oncology Landscape

Contributed by: Business Wire

Logo

Tags

Science

Other Science

Biotechnology

Research

Pharmaceutical

Oncology

Health

Clinical Trials

Survey

More Like This

Biotech companies to increase R&D spend but highlight complexity of clinical trials - ICON

ICON Survey Highlights Sustained Investment in AI and Digital R&D Innovation, Tempered by Siloed Adoption

Biomarker and Trial Optimisation Needed to Drive R&D Progress in Alzheimer’s and Related Disorders – ICON Survey

New ICON Survey Highlights Importance of Combination Therapies in Future Obesity Treatment

ICON Portfolio of AI Tools Drives Clinical Trial Efficiencies

ICON and Its Employees Celebrated for Excellence in the Field of Clinical Research

ICON Recognised for Leadership Position in Clinical Research Industry and as Socially Responsible Employer

ICON Wins Industry Accolades from TIME Magazine, Forbes and Financial Times in Second Half of 2023